Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Everolimus
Related studies linked through entity extraction aliases.
Everolimus and Capecitabine in Patients With Advanced Malignancy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
- Status
- COMPLETED
- Phase
- PHASE2
RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.
- Status
- COMPLETED
- Phase
- PHASE3
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity
- Status
- COMPLETED
- Phase
- PHASE2
Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.
- Status
- COMPLETED
- Phase
- PHASE3
Everolimus in de Novo Heart Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus on CKD Progression in ADPKD Patients
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer
- Status
- COMPLETED
- Phase
- PHASE2